Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility-Reference-Cited by-同舟云学术

Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility

Published:2016-02-12 Issue:2 Volume:11 Page:e0149200
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

An Hongyan,Lim Chai,Guillemin Gilles J.,Vollmer-Conna Ute,Rawlinson William,Bryant Katherine,Tedla Nicodemus

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. Pathogenesis of multiple sclerosis;A Prat;Curr Opin Neurol,2005

2. Role of the innate immune system in the pathogenesis of multiple sclerosis;R Gandhi;J Neuroimmunol,2010

3. The genetics of multiple sclerosis: an up-to-date review;P-A Gourraud;Immunological Reviews,2012

4. Multiple sclerosis;A Nylander;The Journal of Clinical Investigation,2012

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Analysis of Polymorphism rs386000 of the LILRA3 Gene and the Risk of Atherosclerosis Obliterans: a Pilot Study;Kardiologiia;2024-06-30

2. Leukocyte Ig-like receptor A3 facilitates inflammation, migration and invasion of synovial tissue-derived fibroblasts via ERK/JNK activation;Rheumatology;2023-07-18

3. The Role of Leukocyte Immunoglobulin-Like Receptors Focusing on the Therapeutic Implications of the Subfamily B2;Current Drug Targets;2022-11

4. Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APS;Rheumatology;2022-03-24

5. Leukocyte Immunoglobulin-Like Receptors in Regulating the Immune Response in Infectious Diseases: A Window of Opportunity to Pathogen Persistence and a Sound Target in Therapeutics;Frontiers in Immunology;2021-09-14